hERG potassium channel inhibition by ivabradine may contribute to QT prolongation and risk of torsades de pointes.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s | |
| Publication date | August 1, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |